BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28446399)

  • 1. [Inhibiting HSP70 expression enhances cisplatin sensitivity of cervical cancer cells].
    Liu J; Liu J; Li SZ; Zheng YA; Guo SY; Wang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):475-481. PubMed ID: 28446399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
    Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous p53 upregulated modulator of apoptosis (PUMA) decreases growth of lung cancer A549 cells.
    Liu CJ; Zhang XL; Luo DY; Zhu WF; Wan HF; Yang JP; Yang XJ; Wan FS
    Asian Pac J Cancer Prev; 2015; 16(2):741-6. PubMed ID: 25684518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
    Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z; Li F; He S; Zhao L; Wang F
    Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitofusin-2 Triggers Cervical Carcinoma Cell Hela Apoptosis via Mitochondrial Pathway in Mouse Model.
    Wang W; Liu X; Guo X; Quan H
    Cell Physiol Biochem; 2018; 46(1):69-81. PubMed ID: 29587277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells.
    Li X; Zhao J; Yan T; Mu J; Lin Y; Chen J; Deng H; Meng X
    J Food Sci; 2021 Jun; 86(6):2700-2712. PubMed ID: 33908630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Antitumor Efficiency of Zinc Finger Nuclease Combined with Cisplatin and Trichostatin A in Cervical Cancer Cells.
    Ren C; Gao C; Li X; Xiong J; Shen H; Wang L; Zhu D; Wu P; Ding W; Wang H
    Anticancer Agents Med Chem; 2020; 20(17):2125-2135. PubMed ID: 32753022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment.
    Qin L; Xu T; Xia L; Wang X; Zhang X; Zhang X; Zhu Z; Zhong S; Wang C; Shen Z
    Drug Des Devel Ther; 2016; 10():1035-45. PubMed ID: 27022243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IL-17A/lL-17RA reduces cisplatin sensitivity of ovarian cancer SKOV3 cells by regulating autophagy].
    Wang L; Zhang X; Wang L; Wang B; Zhang J; Li Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1550-1556. PubMed ID: 33243748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
    Cai L; Wang Z; Liu D
    Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.
    Guo XF; Liu JP; Ma SQ; Zhang P; Sun WD
    Biomed Pharmacother; 2018 Jul; 103():67-74. PubMed ID: 29635130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of tunicamycin combined with cisplatin on proliferation and apoptosis of human nasopharyngeal carcinoma cells in vitro].
    Song L; Ma L; Zhang X; Jiang Z; Liu H; Jiang C
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):766-71. PubMed ID: 22699051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
    Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion of multidrug resistance by SKI-II in SGC7901/DDP cells and exploration of underlying mechanisms.
    Zhu ZA; Zhu ZQ; Cai HX; Liu Y
    Asian Pac J Cancer Prev; 2012; 13(2):625-31. PubMed ID: 22524836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions.
    Ju X; Yu H; Liang D; Jiang T; Liu Y; Chen L; Dong Q; Liu X
    Biomed Pharmacother; 2018 Jun; 102():549-554. PubMed ID: 29597088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.